Health policymakers and senior officials from the Organisation of Eastern Caribbean States (OECS) convened in Grenada this week for the 38th OECS Pharmaceutical Procurement Service (PPS) Policy Board meeting and the 11th Council of OECS Health Ministers. The gatherings aimed to enhance regional cooperation in improving access to essential medicines and health services. On October 21, 2025, the PPS Policy Board engaged in extensive discussions, focusing on a groundbreaking public-private partnership already operational in St. Lucia and St. Kitts and Nevis. This initiative significantly reduces the cost of insulin, a vital medication for individuals with diabetes, marking a transformative step toward pharmaceutical equity in the region. Grenada’s Minister of Health, Hon. Philip Telesford, who chairs the OECS Council of Health Ministers, officially announced the initiative during a press briefing on October 22, 2025. He urged other member states to adopt similar models to expand affordable insulin access, emphasizing its potential to save lives and alleviate financial burdens for thousands of families. Francis Burnett, Interim Head of OECS-PPS, highlighted the initiative as a major advancement, noting that reduced insulin prices would benefit both public health and procurement budgets. The OECS currently procures approximately 120,000 vials of insulin annually. Dr. Didacus Jules, Director General of the OECS, underscored the importance of regional solidarity in addressing geopolitical, financial, and health challenges. The meetings also addressed broader health priorities, including strengthening pooled procurement systems, expanding access to specialized health services, and enhancing collaboration to tackle potential funding reductions. The two-day event combined technical and strategic planning, resulting in agreements to deepen cooperation and deliver tangible health benefits across the OECS region.